News >

Early Data Support Neoadjuvant Hypofractionated Radiotherapy in Soft Tissue Sarcoma

Ellie Leick
Published: Friday, Nov 08, 2019

Joshua M. Lawrenz, MD, a fellow in musculoskeletal oncology at Vanderbilt University Medical Center

Joshua M. Lawrenz, MD

Neoadjuvant hypofractionated radiotherapy was found to have similar complication rates to the current standard conventional radiotherapy and also resulted in a shorter treatment duration in patients with soft tissue sarcoma, according to preliminary results of a small case study,1,2 explained Joshua M. Lawrenz, MD.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication